nAChRs (Role and Berg, 1996) . We performed doublelabel immunofluorescence studies on mouse brain sections to determine whether lynx1 and nAChRs containing ␣ 4 and ␣ 7 subunits colocalize in the same neurons.
Experiments were done using both monoclonal antibodies raised against purified recombinant lynx1 protein and affinity-purified polyclonal antibodies raised against a lynx1 peptide (see Experimental Procedures). The lynx1 monoclonal antibody (mAb 8589) used in this study was chosen because it specifically stained cells transfected with a lynx1 expression vector (Figures 1A and 1B) and because immunohistochemical studies revealed a pattern of staining similar to that obtained for lynx1 by in situ hybridization (Miwa et al., 1999 ; data not shown). The lynx1 polyclonal antibody has been previously reported (Miwa et al., 1999) . For this study, the crude antiserum was further purified on a peptide affinity column. The specificity of the purified polyclonal antibody for lynx1 was tested by comparative immunofluorescence studies on mouse brain sections ( Figure 2 ) and Western blot (Figure 4 ). The results of these studies establish that both antibody preparations recognize lynx1.
To determine whether lynx1 and the nAChR ␣ 4 subunit are colocalized on the surface of CNS neurons, doubleimmunoflourescence experiments were performed using the lynx1 monoclonal antibody (mAb 8589) and anti-␣ 4 nAChR polyclonal antibody (Rogers et al., 1998) . Colocalization of lynx1 and the ␣ 4 nAChR was evident in specific subsets of neurons in multiple regions within the CNS (Figures 1C-1F ). Particularly strong labeling was detected in cerebral cortex, thalamus, substantia nigra, and cerebellum. In the telencephalon, prominent double-label immunofluorescence was detected on the with extracts from cells transfected with lynx1 only (Figure 3A) demonstrated that lynx1 was not precipitated in the absence of the receptor, with protein G beads alone, or with beads carrying the ␣ 7 monoclonal antibodies. These results demonstrate that lynx1 can form a stable complex with nAChRs in mammalian cells.
To test the specificity of lynx1 association with nicotinic receptors, we used the same immunoprecipitation protocol to look for association of lynx1 with the delta 2 glutamate receptor (Grid2). To ensure that the results of the immunoprecipitations could be directly compared, we used Flag epitope-tagged constructs for all of the receptor subunits and performed the immunoprecipitations for both the ␣ 4 and ␤ 2 nAChRs and Grid2 using anti-Flag antibody beads. Immunoprecipitation of extracts from cells expressing the Flag-tagged ␣ 4 ␤ 2 receptors and lynx1 or Flag-tagged Grid2 receptors and lynx1 significantly enriched both receptor types in the precipitate relative to the input fraction ( Figure 3D ). In contrast, lynx1 was enriched only in the precipitates from cells also expressing the ␣ 4 ␤ 2 receptors, but not in extracts from cells coexpressing the Grid2 receptors.
As an additional control for the specificity of the interaction between lynx1 and nAChRs, we tested whether these receptors could be precipitated with a second unrelated GPI-anchored protein. Immunoprecipitation of extracts from cells transfected with ␣ 4 ␤ 2 receptors and the GPI-linked protein placental alkaline phosphatase (PLAP), under conditions identical to those used to reveal the interaction of the ␣ 4 ␤ 2 nAChR and lynx1, demonstrated clear precipitation of the ␣ 4 and ␤ 2 subunits with the anti-Flag antibodies, as expected, but did not result in coprecipitation of PLAP ( Figure 3E ). This result demonstrates that the association of lynx1 and nAChRs does not result from adventitious coprecipitation due to nonspecific colocalization of nAChRs and GPI-anchored proteins in lipid rafts or other membrane subdomains. Taken together, these experiments establish that lynx1 lynx1 increases both the rate and extent of desensitization of ␣ 4 ␤ 2 receptors. To ensure that the kinetic effects of lynx1 on ␣ 4 ␤ 2 receptors reflect a specific modulation of nAChRs by lynx1, three additional types of control experiments were conducted. First, the possibility that calcium-activated chloride currents contaminate the ACh-evoked currents under our recording conditions was tested. Oocytes were injected with the calcium chelator BAPTA ( Figure 5D ) or incubated with the membrane-permeant form BAPTA-AM (not shown) before recording. No differences were observed in either of these experiments when compared to untreated oocytes, either in the presence or absence of lynx1 ( Figure 5A) . Second, the specificity of lynx1 modulation of nAChRs was tested in coexpression studies of lynx1 and GABA A (␥-aminobutyric acid type A) receptors. GABA-evoked chloride currents were recorded from oocytes expressing GABA A receptors (␣ 1 ␤ 1 ␥ 2 combination) alone or together with lynx1 using voltage-clamp conditions. As shown in Figure 5E , no differences in the rate or extent of desensitization of GABA A receptors were observed. Further experiments at different GABA concentrations (1, 10, 100 M and 1 mM GABA) revealed no differences in the fitted fast time constants (data not shown). Finally, the possibility that lynx1 might also change the capacitance of the oocyte membrane (Isom et al., 1995) was also examined. No change in membrane capacitance was observed be- (before lynx1 application, f ϭ 1.76 Ϯ 0.38 s; during lynx1 application, f ϭ 0.93 Ϯ 0.2 s, n ϭ 11 oocytes). These the sum of two exponentials (corresponding to the fast data are consistent with an increase in nAChR desensitiand slow components) plus a constant. The rate of onset zation in the presence of native GPI-anchored lynx1 of desensitization was quantified by the value of the reported here. However, since soluble lynx1 was applied time constants, fast ( f ) and slow ( s ), obtained in the twoas a pulse in these experiments and since the stability exponential fits ( Figure 5B ). The extent of desensitization of its interaction with nAChRs is not known, the dissociawas determined by the relative contribution of the fast tion of soluble lynx1 from the receptors during the component to the total decay (RC f ) ( Figure 5C ). Coexcourse of the experiments might also contribute to the pression of lynx1 with ␣ 4 ␤ 2 significantly accelerated the kinetics of current decay. f (␣ 4 ␤ 2 : f ϭ 2.73 Ϯ 0.06 s; ␣ 4 ␤ 2 plus lynx1: f ϭ 1.09 Ϯ To assess whether lynx1 affects ACh sensitivity of ␣ 4 ␤ 2 0.07 s) with no alteration of s (Figures 5A and 5B ) and nAChRs, we applied different concentrations of ACh to increased the RC f (Figures 5A and 5C ). Injection of lynx1 oocytes expressing ␣ 4 ␤ 2 in the presence or absence of alone or coinjection of lynx1 with either ␣ 4 or ␤ 2 alone, lynx1. In the presence of lynx1, ␣ 4 ␤ 2 receptors show yielded no detectable macroscopic currents in response reduced sensitivity to ACh, compared to ␣ 4 ␤ 2 alone (Figure 6A) . Dose-response curves generated from the peak to ACh (data not shown). These results indicate that currents reveal a shift of approximately 20-fold toward higher ACh concentrations in the presence of lynx1 (Figure 6B) . From these results, we conclude that coexpression of lynx1 with ␣ 4 ␤ 2 nAChRs in oocytes increases the EC 50 for ACh. To further investigate the effect of lynx1 on desensitization of ␣ 4 ␤ 2 receptors, we used a twopulse protocol to examine the time course of recovery from desensitization induced by ACh. Figure 7A shows representative traces of the ACh-evoked currents elicited in oocytes expressing either ␣ 4 ␤ 2 (upper panel) or ␣ 4 ␤ 2 and lynx1 (lower panel) at increasing times following wash out of the initial desensitizing dose of ACh. At short time intervals following wash out of ACh (5-40 s), the peak amplitude of the second ACh-evoked current pulse is significantly reduced compared to the initial pulse in ␣ 4 ␤ 2 plus lynx1 coinjected oocytes, compared to ␣ 4 ␤ 2 -expressing oocytes. The time course of recovery of the second pulse is described by a single exponential function in both cases. The corresponding time constant is significantly prolonged in oocytes expressing ␣ 4 ␤ 2 plus lynx1 ( Figure 7B ). These results indicate that lynx1 slows recovery from desensitization for ␣ 4 ␤ 2 receptors. lynx1 shares the cysteine-rich consensus motif of the Ly6/neurotoxin superfamily. The disulfide bridges created by these conserved cysteines in ␣-neurotoxins create a rigid ␤ sheet core from which three variable loops emerge (Tsetlin, 1999). To assess the structural specificity of lynx1 action on nAChRs we mutated several cysteines in lynx1 that might be critical for its overall topology. A schematic representation of lynx1, indicating its cysteine bridges, is shown in Figure 8A . We mutated single cysteines (lynx1 mutants C4, C5, C7, and C9) or two cysteines (lynx1 mutants C2C3 and C6C7) to alanine to test the importance of each disulfide bond. We coexpressed each lynx1 mutant with ␣ 4 ␤ 2 nAChRs and examined the desensitization during application of ACh, as described in Figure 4C . No enhancement in the extent of desensitization was observed with lynx1 mutants C2C3, C4, and C6C7 ( Figure 8B ). In contrast, coexpression of lynx1 mutants C5, C7, and C9 with ␣ 4 ␤ 2 receptors caused washed with PBS, harvested in lysis buffer (150 mM NaCl, 50 mM part of its 5Ј untranslated sequences was subcloned into the oocyte HEPES, 100 mM PMSF, 1.5 g/ml aprotinin, 10 g/ml leupeptin, expression vector pCS2ϩ and used for in vitro transcription and and protease inhibitor cocktail) containing 1% Triton X-100 and transfection experiments. lynx1 cysteine mutants were prepared centrifuged at 14,000 rpm for 5 min. Insoluble cell pellets were using the Quick-Change Site-Directed Mutagenesis kit (Stratagene, resuspended in lysis buffer containing 1% NP40 and 0.05% deoxyLa Jolla, CA). All mutations were verified by sequencing. cDNAs cholate for 3 hr at 4ЊC and precleared by centrifugation at 14,000 encoding nAChR ␣ 4 , ␤ 2 , and ␣ 7 subunits were a gift from Dr. Marc rpm for 5 min. Protein G agarose beads (Roche) were used as Ballivet. The cDNAs of the GABA A receptor subunits ␣ 1 , ␤ 1 , and ␥ 2 described by the manufacturer. Essentially, G beads were incubated were a gift from Dr. Myles Akabas. The constructs containing ␣ 7 with either no antibody or monoclonal antibodies mAb 306, mAb and Flag-tagged ␣ 4 and ␤ 2 nAChR cDNAs were a gift from Dr. José 299, or Flag M2 in NP40/deoxycholate lysis buffer for 3 hr at 4ЊC Ramirez-LaTorre. The expression plasmid containing the cDNA of with gentle rocking. Antibody-bound protein G beads were centrifuthe delta 2 glutamate receptor (Grid2) (Zuo et al., 1997) was Flaggated at 5000 rpm for 1 min, supernatants were removed, and the tagged at the N terminus by Dr. Zhenyu Yue. The GPI-anchored precleared transfected cell extracts were incubated with the anti-PLAP expression plasmid was constructed by Dr. Toshifumi body-bound G beads overnight at 4ЊC with gentle rocking. Agarose Tomoda.
beads were extensively washed with NP40/deoxycholate lysis buffer and resuspended in 4ϫ reducing sample buffer (Invitrogen). Cell Antibodies extracts and protein G fractions were loaded on SDS-PAGE gels The rabbit polyclonal antibody against the nAChR ␣ 4 subunit was cRNA injected for these expression control experiments was 5-6 times greater than that used in two-electrode voltage clamp experimM K aspartate, 2 mM MgCl 2 , 1 mM EGTA, 10 mM HEPES (pH 7.4). To avoid desensitization, a second pipette containing 100 M ACh ments. Injected oocytes were homogeneized in oocyte lysis buffer (10% glycerol, 1% Triton X-100, 100 mM PMSF, 1.5 g/ml aprotinin, in depolarizing buffer was positioned near the isolated patch immediately before recording, and ACh was applied by pressure injection. and 10 g/ml leupeptin in extracellular recording solution). Typically, 20 oocytes were homogeneized in 100 l lysis buffer. Homogenates ACh-evoked currents were recorded with an Axoclamp 200B, digitized at 100 kHz using the program Acquire, and filtered at 2 kHz were centrifuged for 20 min at 14,000 rpm and the intermediate phase was collected. Oocyte extracts (15 l) were run in a PAGE for analysis of all-points and open-time histograms using the program TAC (Bruxton Corp.) gel (Novex) and Western blotting was performed as indicated before.
